المؤلفون: Bilal Hameed, Neil Mehta, Amit G. Singal, R. Katie Kelley, Neehar D. Parikh

المصدر: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 19, iss 8
Clinical Gastroenterology and Hepatology

مصطلحات موضوعية: PD-L1, programmed death ligand 1, medicine.medical_treatment, Liver transplantation, Systemic therapy, 0302 clinical medicine, Model for End-Stage Liver Disease, Pandemic, alpha-fetoprotein (AFP), HCC, CMS, Centers for Medicare and Medicaid services, Cancer, COVID-19, Coronavirus disease 2019, AFP, alpha-fetoprotein, Liver Disease, Liver Neoplasms, BCLC, Barcelona Clinic Liver Cancer, Gastroenterology, RETREAT, Risk estimation of tumor recurrence after liver transplantation, LRT, local regional therapy, VEGF, vascular endothelial growth factor, Local, HCV, hepatitis C virus, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Screening, 030211 gastroenterology & hepatology, alpha-Fetoproteins, Patient Safety, Alpha-Fetoprotein, Liver Cancer, medicine.medical_specialty, Carcinoma, Hepatocellular, CTP, Child-Turcotte-Pugh, NASH, non-alcoholic steatohepatitis, AFP, Clinical Sciences, Context (language use), LT, liver transplantation, Lower risk, Article, 03 medical and health sciences, Rare Diseases, SBRT, stereotactic body radiotherapy, Clinical Research, GALAD, gender, age, AFP-L3, AFP, and DCP, medicine, AFP-L3, lectin-reactive alpha-fetoprotein, Humans, DCP, des-gamma carboxyprothrombin, Intensive care medicine, Adverse effect, Pandemics, RCT, randomized control trial, UNOS, United Network for Organ Sharing, Gastroenterology & Hepatology, Hepatology, SARS-CoV-2, business.industry, screening, MELD, Model for End Stage Liver Disease, Prevention, Carcinoma, COVID-19, Evaluation of treatments and therapeutic interventions, Hepatocellular, medicine.disease, TACE, trans-arterial chemoembolization, Coronavirus, HBV, hepatitis B virus, Neoplasm Recurrence, Good Health and Well Being, Neoplasm Recurrence, Local, HCC, hepatocellular carcinoma, Digestive Diseases, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07686baa7bc3f15f14e5a0d806140ee4Test
https://doi.org/10.1016/j.cgh.2020.06.072Test

المؤلفون: Jérôme Boursier, Emmanuel Tsochatzis

المساهمون: Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)

المصدر: JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (2), pp.100219. ⟨10.1016/j.jhepr.2020.100219⟩
JHEP Reports

مصطلحات موضوعية: Cirrhosis, Cost effectiveness, [SDV]Life Sciences [q-bio], NICE, National Institute of Clinical Excellence, Nice, Review, AST, aspartate aminotransferase, Disease, Patient pathway, ELF, enhanced liver fibrosis, 0302 clinical medicine, Immunology and Allergy, Medicine, NFS, NAFLD fibrosis score, ALD, alcohol-related liver disease, ComputingMilieux_MISCELLANEOUS, computer.programming_language, 0303 health sciences, NAS, NAFLD activity score, Case-finding, Fatty liver, Gastroenterology, Awareness, Primary care, TE, transient elastography, 3. Good health, Screening, FIB-4, 030211 gastroenterology & hepatology, Elastography, NAFLD, non-alcoholic fatty liver disease, medicine.medical_specialty, NASH, non-alcoholic steatohepatitis, Liver fibrosis, QALY, quality-adjusted life year, 03 medical and health sciences, ALT, alanine aminotransferase, Type 2 diabetes mellitus, NIT, non-invasive test, Internal Medicine, GP, general practitioner, FIB-4, fibrosis-4, Intensive care medicine, 030304 developmental biology, Hepatology, business.industry, Type 2 Diabetes Mellitus, T2DM, type 2 diabetes mellitus, medicine.disease, Quality-adjusted life year, Cost-effectiveness, Transient elastography, business, computer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::998a5dc5ae8854bb83716af6e6873dc7Test
https://doi.org/10.1016/j.jhepr.2020.100219Test

المؤلفون: Javier Ampuero, Manuel Romero-Gómez

المصدر: JHEP Reports

مصطلحات موضوعية: NAFLD, non-alcoholic fatty liver disease, medicine.medical_specialty, Treatment response, NASH, non-alcoholic steatohepatitis, Review, Comorbidities, NAFLD, Intervention (counseling), Internal Medicine, medicine, Immunology and Allergy, In patient, Intensive care medicine, NAS, NAFLD activity score, Hepatology, business.industry, Metabolic disorder, Gastroenterology, Odds ratio, Lifestyle, medicine.disease, Clinical trial, OR, odds ratio, Natural history, Concomitant, Stratification, Alcohol, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e981f0bd284ce469f91aa8797d8b7aaaTest
https://doi.org/10.1016/j.jhepr.2020.100148Test

المؤلفون: Philip N. Newsome, Markus Cornberg, Thomas Berg, Tobias Boettler, Mario U. Mondelli, Elisa Cordero, Mojca Maticic

المساهمون: Boettler, Tobias, Maticic, Mojca, Cordero, Elisa, Cornberg, Markus, Boettler, Tobias [0000-0002-1195-055X], Maticic, Mojca [0000-0003-4261-0424], Cordero, Elisa [0000-0001-7766-7266], Cornberg, Markus [0000-0002-9141-8001], Universidad de Sevilla. Departamento de Medicina

المصدر: JHEP Reports
Digital.CSIC. Repositorio Institucional del CSIC
instname
JHEP Reports, Vol 2, Iss 3, Pp-(2020)

مصطلحات موضوعية: ACE-I, angiotensin-converting enzyme inhibitor, NAFLD, non-alcoholic fatty liver disease, medicine.medical_specialty, Telemedicine, NASH, non-alcoholic steatohepatitis, PIs, protease inhibitors, medicine.medical_treatment, AST, aspartate aminotransferase, EGD, esophagogastroduodenoscopy, Liver transplantation, ACE2, angiotensin-converting enzyme 2, Chronic liver disease, SARS-CoV-2, severe acute respiratory syndrome coronavirus 2, Article, MELD, model for end-stage liver disease, Liver disease, ULN, upper limit of normal, Model for End-Stage Liver Disease, Baricitinib, ALT, alanine aminotransferase, Health care, Pandemic, Internal Medicine, Immunology and Allergy, Medicine, Pharmacokinetics, RdRp, RNA-dependent RNA polymerase, lcsh:RC799-869, NUC, nucleoside analogue, Intensive care medicine, COVID-19, coronavirus disease 2019, Hepatology, business.industry, Gastroenterology, medicine.disease, Coronavirus, ERC, endoscopic retrograde cholangiography, ACLF, acute-on-chronic liver failure, Position paper, lcsh:Diseases of the digestive system. Gastroenterology, HCC, hepatocellular carcinoma, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::582cd79a12ada0e6ad44a75ade106fe6Test
https://doi.org/10.1016/j.jhepr.2020.100113Test

المؤلفون: Yemi Oluboyede, Gulnar Fattakhova, Lorraine McSweeney, Luke Vale, Lynda C. Doward, Fiona Beyer, Clifford A. Brass, Quentin M. Anstee, Matthew Breckons, Laura Ternent, Maria-Magdalena Balp, Arun J. Sanyal

المصدر: JHEP Reports
JHEP Reports, Vol 2, Iss 3, Pp-(2020)

مصطلحات موضوعية: medicine.medical_treatment, Disease, Liver disease, 0302 clinical medicine, Immunology and Allergy, 030212 general & internal medicine, Non-alcoholic steatohepatitis, education.field_of_study, Gastroenterology, PRO, patient-reported outcome, LDSI, liver disease symptom index, 3. Good health, health-related quality of life, Cirrhosis, 030211 gastroenterology & hepatology, Patient-reported outcome, SF-36, short form health profile 36, Research Article, FDA, United States Food and Drug Administration, RI, researcher interpretation, HRQoL, health-related quality of life, NAFLD, non-alcoholic fatty liver disease, medicine.medical_specialty, SF-36, NASH, non-alcoholic steatohepatitis, Population, liver, digestive system, Support group, MS, multiple sclerosis, 03 medical and health sciences, Quality of life (healthcare), NAFLD, PHAQ, patient-reported outcome measurement information system health assessment questionnaire, Internal Medicine, medicine, NAFL, non-alcoholic fatty liver, CLDQ, chronic liver disease questionnaire, lcsh:RC799-869, Intensive care medicine, education, patient-reported outcome measures, Hepatology, business.industry, nutritional and metabolic diseases, medicine.disease, QoL, quality of life, Mental health, digestive system diseases, FIS, fatigue impact scale, PROM, patient-reported outcome measure, EMA, European Medicines Agency, COSMIN, The COnsensus-based Standards for the selection of health Measurement INstruments, lcsh:Diseases of the digestive system. Gastroenterology, business, LDQoL, liver disease quality of life questionnaire

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee751f2b6ffd99b10142118b951f0fcdTest
https://doi.org/10.1016/j.jhepr.2020.100099Test